ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 182 filers reported holding ACORDA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 4.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $9,000 | -57.1% | 10,079 | 0.0% | 0.00% | – |
| Q4 2019 | $21,000 | -27.6% | 10,079 | 0.0% | 0.00% | – |
| Q3 2019 | $29,000 | -62.3% | 10,079 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $77,000 | -42.5% | 10,079 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $134,000 | -14.6% | 10,079 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $157,000 | -20.7% | 10,079 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $198,000 | -35.3% | 10,079 | -5.6% | 0.00% | -50.0% |
| Q2 2018 | $306,000 | +20.9% | 10,679 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $253,000 | +0.8% | 10,679 | -8.7% | 0.00% | 0.0% |
| Q4 2017 | $251,000 | -9.4% | 11,700 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $277,000 | +20.4% | 11,700 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $230,000 | -6.5% | 11,700 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $246,000 | +11.8% | 11,700 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $220,000 | -56.0% | 11,700 | -51.2% | 0.00% | -50.0% |
| Q3 2016 | $500,000 | -18.2% | 23,970 | 0.0% | 0.01% | -25.0% |
| Q2 2016 | $611,000 | -3.6% | 23,970 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $634,000 | -38.1% | 23,970 | 0.0% | 0.01% | -38.5% |
| Q4 2015 | $1,025,000 | -76.5% | 23,970 | -85.5% | 0.01% | -77.2% |
| Q3 2015 | $4,368,000 | -58.0% | 164,770 | -47.2% | 0.06% | -54.0% |
| Q2 2015 | $10,392,000 | -2.2% | 311,800 | -2.3% | 0.12% | +0.8% |
| Q1 2015 | $10,623,000 | -37.1% | 319,210 | -22.7% | 0.12% | -35.9% |
| Q4 2014 | $16,884,000 | +27.9% | 413,110 | +6.0% | 0.19% | +23.1% |
| Q3 2014 | $13,203,000 | -6.2% | 389,700 | -6.7% | 0.16% | -4.9% |
| Q2 2014 | $14,074,000 | +4.0% | 417,500 | +16.9% | 0.16% | +2.5% |
| Q1 2014 | $13,538,000 | +56.4% | 357,100 | +20.5% | 0.16% | +58.4% |
| Q4 2013 | $8,655,000 | +4.7% | 296,400 | +22.6% | 0.10% | +34.7% |
| Q3 2013 | $8,270,000 | +5.5% | 241,810 | +1.7% | 0.08% | +1.4% |
| Q2 2013 | $7,841,000 | – | 237,670 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |